Difficulty: Medium
Average Score: 80%
Practice
Which of the following antipsychotic agents is preferable in patients with coronary and cerebrovascular disease?
Correct answer
C
Rationale
In patients with coronary and cerebrovascular disease, the preferable antipsychotic agent is Haloperidol (option C). This is because Haloperidol has a lower risk of causing cardiovascular adverse effects compared to other antipsychotic agents.
Chlorpromazine (option A) is not preferred in these patients due to its potential to cause significant hypotension, which can be detrimental in individuals with cardiovascular issues. Fluphenazine (option B) and Perphenazine (option D) also have a higher likelihood of causing cardiovascular side effects, making them less suitable choices for patients with coronary and cerebrovascular disease.
Educationally, understanding the cardiovascular effects of different antipsychotic agents is crucial for safe medication administration in patients with underlying cardiovascular conditions. Healthcare providers need to be aware of the pharmacological profiles of these medications to make informed decisions that optimize patient safety and well-being.
Chlorpromazine (option A) is not preferred in these patients due to its potential to cause significant hypotension, which can be detrimental in individuals with cardiovascular issues. Fluphenazine (option B) and Perphenazine (option D) also have a higher likelihood of causing cardiovascular side effects, making them less suitable choices for patients with coronary and cerebrovascular disease.
Educationally, understanding the cardiovascular effects of different antipsychotic agents is crucial for safe medication administration in patients with underlying cardiovascular conditions. Healthcare providers need to be aware of the pharmacological profiles of these medications to make informed decisions that optimize patient safety and well-being.